Compare PGC & PSNL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PGC | PSNL |
|---|---|---|
| Founded | 1921 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Commercial Banks | Medical Specialities |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 698.4M | 729.1M |
| IPO Year | 1997 | 2019 |
| Metric | PGC | PSNL |
|---|---|---|
| Price | $41.37 | $6.41 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 5 |
| Target Price | ★ $40.50 | $12.20 |
| AVG Volume (30 Days) | 102.5K | ★ 2.2M |
| Earning Date | 04-22-2026 | 05-07-2026 |
| Dividend Yield | ★ 0.48% | N/A |
| EPS Growth | 13.51 | ★ 33.58 |
| EPS | ★ 0.80 | N/A |
| Revenue | ★ $282,995,000.00 | $69,648,000.00 |
| Revenue This Year | $32.39 | $15.34 |
| Revenue Next Year | $12.64 | $41.46 |
| P/E Ratio | $52.28 | ★ N/A |
| Revenue Growth | ★ 24.05 | N/A |
| 52 Week Low | $24.45 | $3.84 |
| 52 Week High | $43.83 | $11.50 |
| Indicator | PGC | PSNL |
|---|---|---|
| Relative Strength Index (RSI) | 55.90 | 52.55 |
| Support Level | $32.44 | $5.81 |
| Resistance Level | $43.83 | $9.64 |
| Average True Range (ATR) | 1.48 | 0.52 |
| MACD | -0.29 | 0.14 |
| Stochastic Oscillator | 39.95 | 59.28 |
Peapack Gladstone Financial Corp is a bank holding company. Through its subsidiaries, the company offers various wealth management, investment banking, and commercial and personal banking solutions to its clients. The company has two reportable segments: Banking, which generates the maximum revenue, and Wealth Management. The Banking segment includes commercial, commercial real estate, multifamily, residential, and consumer lending activities; treasury management services; escrow management; deposit generation; operation of ATMs; telephone and internet banking services; credit card services, etc. The Wealth Management segment offers investment management services for individuals and institutions; personal trust services; and other financial planning and advisory services.
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.